Haemonetics Corp. (HAE)
118.28
-3.01
(-2.48%)
USD |
NYSE |
Oct 16, 16:00
118.38
+0.10
(+0.08%)
Pre-Market: 20:00
Haemonetics Gross Profit Margin (Quarterly) : 56.98% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 56.98% |
| March 31, 2026 | 54.21% |
| December 31, 2025 | 56.47% |
| September 30, 2025 | 56.04% |
| June 30, 2025 | 56.15% |
| March 31, 2025 | 55.03% |
| December 31, 2024 | 52.89% |
| September 30, 2024 | 51.79% |
| June 30, 2024 | 49.62% |
| March 31, 2024 | 49.99% |
| December 31, 2023 | 52.94% |
| September 30, 2023 | 51.34% |
| June 30, 2023 | 51.39% |
| March 31, 2023 | 51.34% |
| December 31, 2022 | 49.32% |
| September 30, 2022 | 50.32% |
| June 30, 2022 | 51.13% |
| March 31, 2022 | 49.24% |
| December 31, 2021 | 48.59% |
| September 30, 2021 | 46.42% |
| June 30, 2021 | 42.87% |
| March 31, 2021 | 46.03% |
| December 31, 2020 | 50.01% |
| September 30, 2020 | 50.37% |
| June 30, 2020 | 46.29% |
| Date | Value |
|---|---|
| March 31, 2020 | 48.82% |
| December 31, 2019 | 49.45% |
| September 30, 2019 | 50.40% |
| June 30, 2019 | 57.50% |
| March 31, 2019 | 46.53% |
| December 31, 2018 | 46.89% |
| September 30, 2018 | 48.16% |
| June 30, 2018 | 47.24% |
| March 31, 2018 | 44.70% |
| December 31, 2017 | 47.55% |
| September 30, 2017 | 46.39% |
| June 30, 2017 | 43.45% |
| March 31, 2017 | 43.01% |
| December 31, 2016 | 44.36% |
| September 30, 2016 | 47.33% |
| June 30, 2016 | 43.89% |
| March 31, 2016 | 36.67% |
| December 31, 2015 | 46.64% |
| September 30, 2015 | 47.93% |
| June 30, 2015 | 48.05% |
| March 31, 2015 | 47.85% |
| December 31, 2014 | 48.17% |
| September 30, 2014 | 47.51% |
| June 30, 2014 | 47.34% |
| March 31, 2014 | 47.51% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Globus Medical, Inc. | 65.92% |
| Abbott Laboratories | 52.64% |
| ICU Medical, Inc. | 36.74% |
| Merit Medical Systems, Inc. | 51.20% |
| Teleflex, Inc. | 58.12% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 11.26% |
| Return on Assets | 3.96% |
| Return on Invested Capital | 4.63% |
| Profit Margin (Quarterly) | 9.73% |
| Operating Margin (Quarterly) | 17.61% |
| Return on Net Operating Assets | 5.05% |